期刊論文1. | Olivier D,、Lubman D I,、Fraser R.(2007)。Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective。Aust N Z J Psychiatry,41,572-80。 |
2. | Ratschen E,、Britton J,、McNeill A.(2011)。The smoking culture in psychiatry: time for change。Br J Psychiatry,198,6-7。 |
3. | 吳恩亮、陳建志、詹宏裕、簡以嘉、歐麗玲、陳快樂(20130900)。Smoking Behaviors among Psychiatric Inpatients in Taiwan。臺灣精神醫學,27(3),238-244+266。 延伸查詢 |
4. | Lawn S,、Condon J.(2006)。Psychiatric nurses’ ethical stance on cigarette smoking by patients: determinants and dilemmas in their role in supporting cessation。Int J Ment Health Nurs,15,111-118。 |
5. | McEvoy JP,、Freudenreich O,、Levin ED,、Rose JE.(1995)。Haloperidol increases smoking in patients with schizophrenia。Psychopharmacology (Berl),119,124-126。 |
6. | Kelly C,、McCreadie R G.(1999)。Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland。Am J Psychiatry,156,1751-1757。 |
7. | Lyons MJ,、Bar JL,、Kremen WS, et al.(2002)。Nicotine and familial vulnerability to schizophrenia: a discordant twin study。J Abnorm Psychol,111,687-693。 |
8. | Volkow ND,、Wang GJ,、Tomasi D, et al.(2010)。Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers。PLOS One,5,11509。 |
9. | Berridge KC.(2007)。The debate over dopamine’s role in reward: the case for incentive salience。Psychopharmacology (Berl),191,391-431。 |
10. | Agarwal DP,、Goedde HW.(1992)。Pharmacogenetics of alcohol metabolism and alcoholism。Pharmacogenetics,2,48-62。 |
11. | Osborn DP,、Levy G,、Nazareth I,、Petersen I,、Islam A,、King MB.(2007)。Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdomâs General Practice Research Database。Arch Gen Psychiatry,64,242-249。 |
12. | Banham L,、Gilbody S.(2010)。Smoking cessation in severe mental illness: what works。Addiction,105,1176-1189。 |
13. | Tsoi DT,、Porwal M,、Webster AC.(2010)。Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis。Br J Psychiatry,196,346-353。 |
14. | Ratschen E,、Britton J,、Doody GA,、Leonardi-Bee J,、McNeill A.(2009)。Tobacco dependence, treatment and smoke-free policies: a survey of mental health professionalsâ knowledge and attitudes。Gen Hosp Psychiatry,31,576-582。 |
15. | de Leon J,、Becona E,、Gurpegui M,、Gonzalez-Pinto A,、Diaz FJ(2002)。The association between high nicotine dependence and severe mental illness may be consistent across countries。J Clin Psychiatry,63,812-816。 |
16. | Brown, S.、Inskip, H.、Barraclough, B.(2000)。Causes of the excess mortality of schizophrenia。British Journal of Psychiatry,177,212-217。 |
17. | Howes, O. D.、Kapur, S.(2009)。The dopamine hypothesis of schizophrenia: version III--the final common pathway。Schizophrenia Bulletin,35(3),549-562。 |
18. | Thomasson, H. R.、Edenberg, H. J.、Crabb, D. W.、Mai XL、Jerome, R. E.、Li, Ting-Kai、Wang, S. P.、Lin, Y. T.、陸汝斌、尹士俊(1991)。Alcohol and Aldehyde Dehydrogenase Genotypes and Alcoholism in Chinese Men。American Journal of Human Genetics,48(4),677-681。 |
19. | Keung, W. M.、Vallee, B. L.(1998)。Daidzin and Its Antidipsotropic Analogs Inhibit Serotonin and Dopamine Metabolism in Isolated Mitochondria。Proceedings of the National Academy of Sciences of the United States of America,95(5),2198-2203。 |
20. | Chen CC,、Lu RB,、Chen YC, et al.(1999)。Interaction between the functional polymorphisms of the alcoholmetabolism genes in protection against alcoholism。Am J Hum Genet,65,795-807。 |
21. | Desai HD,、Seabolt J,、Jann MW(2001)。Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective。CNS Drugs,15,469-94。 |